LEO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.438200E-01
Normal-vs-Stage2
3.025800E-01
Normal-vs-Stage3
7.153400E-01
Normal-vs-Stage4
3.027800E-01
Stage1-vs-Stage2
3.481200E-01
Stage1-vs-Stage3
3.195400E-01
Stage1-vs-Stage4
6.203200E-01
Stage2-vs-Stage3
5.295400E-01
Stage2-vs-Stage4
6.590400E-01
Stage3-vs-Stage4
5.299000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.043600E-01
Normal-vs-AfricanAmerican
1.292410E-01
Normal-vs-Asian
4.139400E-01
Caucasian-vs-AfricanAmerican
2.997200E-01
Caucasian-vs-Asian
9.102200E-01
AfricanAmerican-vs-Asian
3.959800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.851800E-01
Normal-vs-Female
3.123600E-01
Male-vs-Female
9.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.942600E-01
Normal-vs-Age(41-60Yrs)
1.470750E-01
Normal-vs-Age(61-80Yrs)
3.883200E-01
Normal-vs-Age(81-100Yrs)
4.660000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.771800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.689400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.468000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.160040E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.512800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.449400E-01
Normal-vs-Daily Drinker
6.825200E-01
Normal-vs-Weekly Drinker
5.014000E-01
Normal-vs-Occasional Drinker
1.644400E-01
Normal-vs-Social Drinker
4.371800E-01
Non Drinker-vs-Daily Drinker
3.413000E-01
Non Drinker-vs-Weekly Drinker
5.615200E-01
Non Drinker-vs-Occasional Drinker
2.175600E-01
Non Drinker-vs-Social Drinker
4.550000E-01
Daily Drinker-vs-Weekly Drinker
7.784800E-01
Daily Drinker-vs-Occasional Drinker
6.484200E-02
Daily Drinker-vs-Social Drinker
8.371200E-01
Weekly Drinker-vs-Occasional Drinker
1.267830E-01
Weekly Drinker-vs-Social Drinker
9.121000E-01
Occasional Drinker-vs-Social Drinker
7.630400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.463500E-02
Normal-vs-Grade 2
2.690400E-02
Normal-vs-Grade 3
1.790310E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.998000E-01
Grade 1-vs-Grade 3
8.575200E-01
Grade 1-vs-Grade 4
6.463500E-02
Grade 2-vs-Grade 3
8.078200E-01
Grade 2-vs-Grade 4
2.690400E-02
Grade 3-vs-Grade 4
1.790310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.067000E-01
Normal-vs-NonDiabetic
2.841400E-01
Diabetic-vs-NonDiabetic
2.371600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.476400E-01
Normal-vs-NoPancreatitis
3.240200E-01
Pancreatitis-vs-NoPancreatitis
7.943200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.711200E-01
Normal-vs-N1
2.895200E-01
N0-vs-N1
3.719000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.780560E-01
Normal-vs-TP53-NonMutant
2.848200E-01
TP53-Mutant-vs-TP53-NonMutant
7.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
